Marc R. Bloomenstein, OD, FAAO

With FDA approval of LENZ Therapeutics’ Vizz (LNZ100), optometrists now have a daily, non-invasive treatment option for presbyopia, giving patients more freedom and clinicians greater flexibility in care.

Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.

Marc Bloomenstein, OD, FAAO, gives inside scoop into some of the most exciting education opportunities at Vision Expo West, including the conference's "Case Files" series.

Marc Bloomenstein, OD, FAAO, discusses how optometrists can proactively manage Demodex blepharitis by regularly examining eyelids, diagnosing the condition early, and offering treatments to effectively eradicate the mites and prevent future complications.

Marc R Bloomenstein, OD, FAAO, chats with Optometry Times on the benefits of using Vevye to treat dry eye disease, when to prescribe, and how to distinguish quality candidates.

TearCare provides significant improvements in dry eye signs and symptoms, superior to Restasis in tear film break-up time improvements.

Easy-to-use modality offers exciting benefits for patients.

This neural time warp is seen throughout the optometric examination.

Being a selfless provider will earn you trust and loyalty.

The pros and cons of LASIK, PRK, EVO, SMILE, and RLE/CLE.

Marc R. Bloomenstein, OD, FAAO, gives an overview of the SAHARA study.

Marc R. Bloomenstein, OD, FAAO, shares key takeaways from his EyeCon 2022 presentation, "Advances in presbyopia."

As technology advances and choices grow, you need to personalize patients’ options.

Evolving phakic IOL offers high-definition vision.

Marc Bloomenstein, OD, FAAO, shares key takeaways from his VEW 2022 presentation, "Corneal relationship therapy: managing the neurotrophic keratitis."

There will be very little downside to optometrists and their practice in offering presbyopia-correcting drops to patients who want better vision without glasses or contact lenses.

Veteran optometrist has seen them all and is waiting for the next innovation

Go beyond flattering frames by enhancing appearance from the exam chair

The earlier patients are prepared for surgery, the better the outcomes will be

Despite the pandemic, ODs have the ability to energize patients about eye health

From sanitation, to temperatures, and telemedicine, here’s how one OD’s practice thrives post COVID-19

The introduction of micro-invasive glaucoma surgery (MIGS) has helped to successfully treat glaucoma patients. Take a look at why MIGS may be a useful treatment option prior to late-stage glaucoma.

Preparing a patient for ocular surgery can pose challenges with cosmetics being widely used. Marc Bloomenstein, OD, with the advice of Optometry Times Editorial Advisory Board member Whitney Hauser, OD, discusses the importance of properly preparing cosmetic users for eye surgery.

I am again reminding you that optometry has a renewed purpose in the management of our cataract and refractive patients.

The longer the time since the last outbreak, the better

A U.S. patent was granted to Gholam A. Peyman, MD, in June 1989 for a method of modifying the corneal curvature of the eye. The surgical procedure involved cutting a flap in the cornea, pulling the flap back to expose the corneal bed, ablating the exposed surface and then replacing the flap. The current procedure of laser assisted in-situ keratomileusis (LASIK) was not FDA approved until 1999.

Historically, optometry and ophthalmology have worked in parallel universes with very little room to cross paths. Yet, this model didn’t provide the appropriate care necessary for our aging populace.

Cataract surgery has entered that technology zone enabling surgeons the opportunity to provide sutureless and bladeless surgery, in vivo axis orientation and aberrometry measurements, and now, remove the drops from this pervasive procedure.